1. 1666PDTrilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy. (23rd October 2018) Authors: Dragnev, K H; Owonikoko, T K; Csoszi, T; Maglakelidze, M; Beck, J T; Domine Gomez, M; Lowczak, A; Fulop, A; Hoyer, R J; Hanna, W; Lowry, P; Aljumaily, R; Chiu, V K; Bulat, I; Yang, Z; Roberts, P J; Antal, J M; Malik, R K; Morris, S R; Weiss, J M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗